vimarsana.com

Page 4 - கைரோஸ் ப்ரோடீந் தொழில்நுட்பங்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Gyros Protein Technologies launches Gyrolab Bioaffy 4000 CD

Product News: Gyros Protein Technologies introduces Gyrolab Bioaffy 4000 CD to extend sensitivity of immunoassay CD range Enables researchers to generate more data in less time to support both preclinical and clinical studies 28 Jan 2021 Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and a leading provider of peptide synthesizers and reagents, has announced the introduction of Gyrolab ® Bioaffy™ 4000 CD for immunoassay applications in biotherapeutic workflows. The new Gyrolab Bioaffy 4000, with a 4000 nL sample volume, is based on the proven design of Gyrolab Bioaffy 1000 CD, allowing seamless assay transfer between CD types and enabling researchers to improve productivity. The new CD adds to the Company’s existing immunoassay technology, including Gyrolab Bioaffy CDs, which together cover broad analytical ranges of more than 6 logs. Gyrolab Bioaffy 4000 CD is designed to meet customer requests for extended sensitivity for more demanding

Catch highlights from the Virtual Biopharmaceutical Summit 2020

Editorial Article: Catch highlights from the Virtual Biopharmaceutical Summit 2020 Top talks and resources exploring the latest research and methods in the field are now available on demand 18 Dec 2020 Explore the latest biopharmaceutical research and techniques here Thousands of scientists from across the world have joined leading manufacturers online to drive forward biopharma research and explore the latest technologies.   The successful Virtual Biopharmaceutical Summit 2020 featured the latest developments, most exciting innovations and biggest stories from across the field, from gene and cell therapy to nanomedicines, drug discovery, LC method development, personalized vaccines, antibody-drug conjugates and more. The new SelectScience ®  Virtual Summits offer a crucial interactive platform for the science industry to continue to connect, share knowledge and provide technology solutions in order to advance science and health at this critical time. With around 4,500 t

Catch highlights from the Virtual Biopharmaceutical Summit 2020

Editorial Article: Catch highlights from the Virtual Biopharmaceutical Summit 2020 Top talks and resources exploring the latest research and methods in the field are now available on demand 18 Dec 2020 Explore the latest biopharmaceutical research and techniques here Thousands of scientists from across the world have joined leading manufacturers online to drive forward biopharma research and explore the latest technologies.   The successful Virtual Biopharmaceutical Summit 2020 featured the latest developments, most exciting innovations and biggest stories from across the field, from gene and cell therapy to nanomedicines, drug discovery, LC method development, personalized vaccines, antibody-drug conjugates and more. The new SelectScience ®  Virtual Summits offer a crucial interactive platform for the science industry to continue to connect, share knowledge and provide technology solutions in order to advance science and health at this critical time. With around 4,500 t

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.